Gemmer Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Gemmer Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-167	Closed	-$2K	–	1018
2022 Q1	$2K	Sell	167 -83	-33%	-$1.22K	﹤0.01%	1162
2021 Q4	$3K	Hold	250	–	–	﹤0.01%	1145
2021 Q3	$4K	Hold	250	–	–	﹤0.01%	1068
2021 Q2	$4K	Hold	250	–	–	﹤0.01%	1216
2021 Q1	$5K	Hold	250	–	–	﹤0.01%	1087
2020 Q4	$5K	Sell	250 -41	-14%	-$719	﹤0.01%	1011
2020 Q3	$5K	Hold	291	–	–	﹤0.01%	891
2020 Q2	$5K	Hold	291	–	–	﹤0.01%	867
2020 Q1	$4K	Buy	291 +229	+369%	+$4.15K	﹤0.01%	869
2019 Q4	$1K	Hold	62	–	–	﹤0.01%	1313
2019 Q3	$1K	Buy	+62	New	+$1.07K	﹤0.01%	1347
2019 Q2	–	Sell	-193	Closed	-$4K	–	1434
2019 Q1	$4K	Buy	+193	New	+$3.88K	﹤0.01%	1107

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Gemmer Asset Management's TAK Position: Q2 2022 in Review

Gemmer Asset Management sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 167 shares — an estimated $2K sold.

Gemmer Asset Management first reported a position in TAK in Q1 2019 and held it in 12 quarters. The position peaked at $5K in Q1 2021. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Gemmer Asset Management reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 167 Takeda Pharmaceutical shares in Q2 2022, an estimated $2K.
Gemmer Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 12 quarters.
Gemmer Asset Management's Takeda Pharmaceutical position peaked at $5K in Q1 2021.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.